Asia
For the past nine years, Saynor has been with GSK, most recently serving as senior vice president and global head of classic and established medicines.
ADC Therapeutics, based in Lausanne, Switzerland, and Adagene, headquartered in Suzhou, China and San Francisco, announced a discovery collaboration and license deal.
Israel-based Teva Pharmaceuticals announced that it is halting the clinical development of fremanezumab (Ajovy) for cluster headaches. They based the decision on a pre-specified futility analysis of a Phase III clinical trial in episodic cluster headaches.
Eddingpharm forked over $375 million for the rights to sell Ceclor and Vancocin in China, as well as a manufacturing facility that makes the two medications.
TLC announced that the company’s management team will be presenting at the following conferences
The FDA said the approval of Teva’s product is the first generic naloxone nasal spray for use in a community setting by individuals without medical training.
Contributing to the development of maternal and child health, and medical information in Kenya
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The gene sequencing industry has really taken off in recent years. Here’s a look at the top five genome sequencing companies, ranked by revenue.
Pharma and biotechs from across the globe share news, pipeline updates, with stories from Vetter, Atomwise, Tessa, GenSight, and more.
PRESS RELEASES